NCT02540330View on ClinicalTrials.gov

A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 13, 2020

Study Completion Date

August 13, 2020

Conditions
Female Breast CarcinomaFemale Ductal Carcinoma In Situ
Interventions
DRUG

Fulvestrant

Trial Locations (3)

10032

Columbia University Medical Center, New York

10461

Montefiore Medical Center, The Bronx

21205

The Johns Hopkins School of Medicine, Baltimore

Sponsors
All Listed Sponsors
lead

Atossa Therapeutics, Inc.

INDUSTRY